ELIQUENT Life Sciences (ELIQUENT), a global regulatory, quality, and safety consulting firm, announces the acquisition of Truliant Consulting (Truliant), a leading pharmacovigilance, risk management, and regulatory compliance advisory firm. This strategic acquisition reinforces ELIQUENT’s position as a premier provider of end-to-end support for every stage of the product lifecycle. The integration of Truliant’s tailored, technology-driven service offerings expands ELIQUENT’s pharmacovigilance platform to provide an even broader range of solutions across processes optimization, integration of cutting-edge technologies, and ability to build scalable pharmacovigilance programs.
Read the full article: ELIQUENT Life Sciences Announces Strategic Acquisition of Leading Pharmacovigilance Firm Truliant Consulting & Expanded Pharmacovigilance Platform //
Source: https://www.businesswire.com/news/home/20250402557387/en/ELIQUENT-Life-Sciences-Announces-Strategic-Acquisition-of-Leading-Pharmacovigilance-Firm-Truliant-Consulting-Expanded-Pharmacovigilance-Platform